We are a molecular diagnostics company that develops, manufactures and markets fully-integrated systems for testing in the Clinical and Non-Clinical markets. Our systems enable fast, sophisticated molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. Molecular testing historically has involved a number of complicated and time-intensive steps including sample preparation, DNA amplification and detection. Our easy-to-use systems integrate these steps and analyze complex biological samples in our proprietary test cartridges. We were first to the U.S. market with a Clinical Laboratory Improvement Amendments (“CLIA”) moderate complexity categorization for an amplified molecular test and the majority of our products are moderately complex, expanding our market opportunity beyond high complexity laboratories.
Company profile
Ticker
CPHD
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
770441625
Latest filings (excl ownership)
15-12G
Securities registration termination
17 Nov 16
CT ORDER
Confidential treatment order
17 Nov 16
25-NSE
Exchange delisting
7 Nov 16
8-K
Completion of Acquisition or Disposition of Assets
7 Nov 16
S-8 POS
Registration of securities for employees (post-effective amendment)
7 Nov 16
S-8 POS
Registration of securities for employees (post-effective amendment)
7 Nov 16
S-8 POS
Registration of securities for employees (post-effective amendment)
7 Nov 16
S-8 POS
Registration of securities for employees (post-effective amendment)
7 Nov 16
S-8 POS
Registration of securities for employees (post-effective amendment)
7 Nov 16
S-8 POS
Registration of securities for employees (post-effective amendment)
7 Nov 16
Latest ownership filings
SC 13G/A
Beneficial ownership report (amended)
7 Feb 17
4
ROBERT J EASTON
7 Nov 16
4
Bill Murray
7 Nov 16
4
JOHN L BISHOP
7 Nov 16
4
Dan Madden
7 Nov 16
4
Scott A. Campbell
7 Nov 16
4
GLENN JR MD PHD STEELE
7 Nov 16
4
Mike Fitzgerald
7 Nov 16
4
CRISTINA KEPNER
7 Nov 16
4
WARREN C KOCMOND JR
7 Nov 16
Institutional ownership, Q3 2019
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|